Works matching AU Weintraub, Daniel

Results: 268
    1
    2
    3
    4
    5
    6
    7

    Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.

    Published in:
    Movement Disorders, 2023, v. 38, n. 7, p. 1236, doi. 10.1002/mds.29410
    By:
    • Jost, Stefanie T.;
    • Kaldenbach, Marie‐Ann;
    • Antonini, Angelo;
    • Martinez‐Martin, Pablo;
    • Timmermann, Lars;
    • Odin, Per;
    • Katzenschlager, Regina;
    • Borgohain, Rupam;
    • Fasano, Alfonso;
    • Stocchi, Fabrizio;
    • Hattori, Nobutaka;
    • Kukkle, Prashanth Lingappa;
    • Rodríguez‐Violante, Mayela;
    • Falup‐Pecurariu, Cristian;
    • Schade, Sebastian;
    • Petry‐Schmelzer, Jan Niklas;
    • Metta, Vinod;
    • Weintraub, Daniel;
    • Deuschl, Guenther;
    • Espay, Alberto J.
    Publication type:
    Article
    8

    Scales for Antipsychotic‐Associated Movement Disorders: Systematic Review, Critique, and Recommendations.

    Published in:
    Movement Disorders, 2023, v. 38, n. 6, p. 1008, doi. 10.1002/mds.29392
    By:
    • Martino, Davide;
    • Karnik, Vikram;
    • Bhidayasiri, Roongroj;
    • Hall, Deborah A.;
    • Hauser, Robert A.;
    • Macerollo, Antonella;
    • Pringsheim, Tamara M.;
    • Truong, Daniel;
    • Factor, Stewart A.;
    • Skorvanek, Matej;
    • Schrag, Anette;
    • Tosin, Michelle H. S.;
    • Shukla, Aparna Wagle;
    • Espay, Alberto;
    • Wu, Ruey‐Meei;
    • Kovacs, Norbert;
    • Meissner, Wassilios;
    • Kleiner, Galit;
    • Markaki, Ioanna;
    • Weintraub, Daniel
    Publication type:
    Article
    9
    10

    Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.

    Published in:
    Movement Disorders, 2021, v. 36, n. 12, p. 2945, doi. 10.1002/mds.28779
    By:
    • Aamodt, Whitley W.;
    • Waligorska, Teresa;
    • Shen, Junchao;
    • Tropea, Thomas F.;
    • Siderowf, Andrew;
    • Weintraub, Daniel;
    • Grossman, Murray;
    • Irwin, David;
    • Wolk, David A.;
    • Xie, Sharon X.;
    • Trojanowski, John Q.;
    • Shaw, Leslie M.;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    11
    12

    Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.

    Published in:
    Movement Disorders, 2021, v. 36, n. 8, p. 1972, doi. 10.1002/mds.28608
    By:
    • Kremer, Thomas;
    • Taylor, Kirsten I.;
    • Siebourg‐Polster, Juliane;
    • Gerken, Thomas;
    • Staempfli, Andreas;
    • Czech, Christian;
    • Dukart, Juergen;
    • Galasko, Douglas;
    • Foroud, Tatiana;
    • Chahine, Lana M.;
    • Coffey, Christopher S.;
    • Simuni, Tanya;
    • Weintraub, Daniel;
    • Seibyl, John;
    • Poston, Kathleen L.;
    • Toga, Arthur W.;
    • Tanner, Caroline M.;
    • Marek, Kenneth;
    • Hutten, Samantha J.;
    • Dziadek, Sebastian
    Publication type:
    Article
    13

    Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.

    Published in:
    Movement Disorders, 2020, v. 35, n. 11, p. 1999, doi. 10.1002/mds.28206
    By:
    • Mollenhauer, Brit;
    • Dakna, Mohammed;
    • Kruse, Niels;
    • Galasko, Douglas;
    • Foroud, Tatiana;
    • Zetterberg, Henrik;
    • Schade, Sebastian;
    • Gera, Roland G.;
    • Wang, Wenting;
    • Gao, Feng;
    • Frasier, Mark;
    • Chahine, Lana M.;
    • Coffey, Christopher S.;
    • Singleton, Andrew B.;
    • Simuni, Tanya;
    • Weintraub, Daniel;
    • Seibyl, John;
    • Toga, Arthur W.;
    • Tanner, Caroline M.;
    • Kieburtz, Karl
    Publication type:
    Article
    14
    15
    16
    17

    Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.

    Published in:
    2020
    By:
    • Simuni, Tanya;
    • Brumm, Michael C.;
    • Uribe, Liz;
    • Caspell‐Garcia, Chelsea;
    • Coffey, Christopher S.;
    • Siderowf, Andrew;
    • Alcalay, Roy N.;
    • Trojanowski, John Q.;
    • Shaw, Leslie M.;
    • Seibyl, John;
    • Singleton, Andrew;
    • Toga, Arthur W.;
    • Galasko, Doug;
    • Foroud, Tatiana;
    • Nudelman, Kelly;
    • Tosun‐Turgut, Duygu;
    • Poston, Kathleen;
    • Weintraub, Daniel;
    • Mollenhauer, Brit;
    • Tanner, Caroline M.
    Publication type:
    journal article
    18
    19
    20

    Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

    Published in:
    2019
    By:
    • Evans, Andrew H.;
    • Okai, David;
    • Weintraub, Daniel;
    • Lim, Shen‐Yang;
    • O'Sullivan, Sean S.;
    • Voon, Valerie;
    • Krack, Paul;
    • Sampaio, Cristina;
    • Post, Bart;
    • Leentjens, Albert F.G.;
    • Martinez‐Martin, Pablo;
    • Stebbins, Glenn T.;
    • Goetz, Christopher G.;
    • Schrag, Anette;
    • Bhidayasiri, Roongroj;
    • Brown, Richard G.;
    • Marinus, Johan;
    • Mestre, Tiago A.;
    • Violante, Mayela Rodriguez;
    • Skorvanek, Matej
    Publication type:
    journal article
    21
    22

    Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

    Published in:
    2019
    By:
    • Hoogland, Jeroen;
    • Boel, Judith A.;
    • Bie, Rob M.A.;
    • Schmand, Ben A.;
    • Geskus, Ronald B.;
    • Dalrymple‐Alford, John C.;
    • Marras, Connie;
    • Adler, Charles H.;
    • Weintraub, Daniel;
    • Junque, Carmen;
    • Pedersen, Kenn F.;
    • Mollenhauer, Brit;
    • Goldman, Jennifer G.;
    • Tröster, Alexander I.;
    • Burn, David J.;
    • Litvan, Irene;
    • Geurtsen, Gert J.;
    • de Bie, Rob M A;
    • Dalrymple-Alford, John C;
    • MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”
    Publication type:
    journal article
    23

    Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

    Published in:
    2019
    By:
    • Seppi, Klaus;
    • Ray Chaudhuri, K.;
    • Coelho, Miguel;
    • Fox, Susan H.;
    • Katzenschlager, Regina;
    • Perez Lloret, Santiago;
    • Weintraub, Daniel;
    • Sampaio, Cristina;
    • Chahine, Lana;
    • Hametner, Eva‐Maria;
    • Heim, Beatrice;
    • Lim, Shen‐Yang;
    • Poewe, Werner;
    • Djamshidian‐Tehrani, Atbin;
    • and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee;
    • the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee
    Publication type:
    journal article
    24
    25
    26

    Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.

    Published in:
    2018
    By:
    • Simuni, Tanya;
    • Siderowf, Andrew;
    • Lasch, Shirley;
    • Coffey, Chris S.;
    • Caspell‐Garcia, Chelsea;
    • Jennings, Danna;
    • Tanner, Caroline M.;
    • Trojanowski, John Q.;
    • Shaw, Leslie M.;
    • Seibyl, John;
    • Schuff, Norbert;
    • Singleton, Andrew;
    • Kieburtz, Karl;
    • Toga, Arthur W.;
    • Mollenhauer, Brit;
    • Galasko, Doug;
    • Chahine, Lana M.;
    • Weintraub, Daniel;
    • Foroud, Tatiana;
    • Tosun, Duygu
    Publication type:
    journal article
    27
    28
    29
    30
    31

    Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

    Published in:
    2018
    By:
    • Skorvanek, Matej;
    • Goldman, Jennifer G.;
    • Jahanshahi, Marjan;
    • Marras, Connie;
    • Rektorova, Irena;
    • Schmand, Ben;
    • van Duijn, Erik;
    • Goetz, Christopher G.;
    • Weintraub, Daniel;
    • Stebbins, Glenn T.;
    • Martinez‐Martin, Pablo;
    • the members of the MDS Rating Scales Review Committee;
    • Martinez-Martin, Pablo;
    • members of the MDS Rating Scales Review Committee
    Publication type:
    journal article
    32
    33
    34
    35

    Arguing against the proposed definition changes of PD.

    Published in:
    2016
    By:
    • Boeve, Bradley F.;
    • Dickson, Dennis W.;
    • Duda, John E.;
    • Ferman, Tanis J.;
    • Galasko, Douglas R.;
    • Galvin, James E.;
    • Goldman, Jennifer G.;
    • Growdon, John H.;
    • Hurtig, Howard I.;
    • Kaufer, Daniel I.;
    • Kantarci, Kejal;
    • Leverenz, James B.;
    • Lippa, Carol F.;
    • Lopez, Oscar L.;
    • McKeith, Ian G.;
    • Singleton, Andrew B.;
    • Taylor, Angela;
    • Tsuang, Debby;
    • Weintraub, Daniel;
    • Zabetian, Cyrus P.
    Publication type:
    journal article
    36
    37
    38
    39
    40
    41
    42

    GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

    Published in:
    2016
    By:
    • Mata, Ignacio F.;
    • Leverenz, James B.;
    • Weintraub, Daniel;
    • Trojanowski, John Q.;
    • Chen‐Plotkin, Alice;
    • Deerlin, Vivianna M.;
    • Ritz, Beate;
    • Rausch, Rebecca;
    • Factor, Stewart A.;
    • Wood‐Siverio, Cathy;
    • Quinn, Joseph F.;
    • Chung, Kathryn A.;
    • Peterson‐Hiller, Amie L.;
    • Goldman, Jennifer G.;
    • Stebbins, Glenn T.;
    • Bernard, Bryan;
    • Espay, Alberto J.;
    • Revilla, Fredy J.;
    • Devoto, Johnna;
    • Rosenthal, Liana S.
    Publication type:
    journal article
    43
    44
    45
    46

    Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

    Published in:
    Movement Disorders, 2015, v. 30, n. 7, p. 919, doi. 10.1002/mds.26170
    By:
    • Weintraub, Daniel;
    • Simuni, Tanya;
    • Caspell‐Garcia, Chelsea;
    • Coffey, Christopher;
    • Lasch, Shirley;
    • Siderowf, Andrew;
    • Aarsland, Dag;
    • Barone, Paolo;
    • Burn, David;
    • Chahine, Lama M.;
    • Eberling, Jamie;
    • Espay, Alberto J.;
    • Foster, Eric D.;
    • Leverenz, James B.;
    • Litvan, Irene;
    • Richard, Irene;
    • Troyer, Matthew D.;
    • Hawkins, Keith A.
    Publication type:
    Article
    47

    Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.

    Published in:
    Movement Disorders, 2015, v. 30, n. 6, p. 805, doi. 10.1002/mds.26022
    By:
    • Swanson, Christine R.;
    • Li, Katherine;
    • Unger, Travis L.;
    • Gallagher, Michael D.;
    • Van Deerlin, Vivianna M.;
    • Agarwal, Pinky;
    • Leverenz, James;
    • Roberts, John;
    • Samii, Ali;
    • Gross, Rachel Goldmann;
    • Hurtig, Howard;
    • Rick, Jacqueline;
    • Weintraub, Daniel;
    • Trojanowski, John Q.;
    • Zabetian, Cyrus;
    • Chen‐Plotkin, Alice S.
    Publication type:
    Article
    48
    49
    50

    Cognitive profile of LRRK2-related Parkinson's disease.

    Published in:
    Movement Disorders, 2015, v. 30, n. 5, p. 728, doi. 10.1002/mds.26161
    By:
    • Srivatsal, Sindhu;
    • Cholerton, Brenna;
    • Leverenz, James B.;
    • Wszolek, Zbigniew K.;
    • Uitti, Ryan J.;
    • Dickson, Dennis W.;
    • Weintraub, Daniel;
    • Trojanowski, John Q.;
    • Van Deerlin, Vivianna M.;
    • Quinn, Joseph F.;
    • Chung, Kathryn A.;
    • Peterson, Amie L.;
    • Factor, Stewart A.;
    • Wood‐Siverio, Cathy;
    • Goldman, Jennifer G.;
    • Stebbins, Glenn T.;
    • Bernard, Bryan;
    • Ritz, Beate;
    • Rausch, Rebecca;
    • Espay, Alberto J.
    Publication type:
    Article